- Nutrients work in networks. Vitamin D, magnesium and vitamin K, or folate, B12 and B6, depend on each other to do their jobs.
- Higher doses don't reliably mean more benefit. Several large trials of single high-dose supplements found no benefit, and some found harm.
- The big multivitamin trials show modest, real effects, not miracles. No trial proves that any one blend, including ours, works better than another.
- Everyday pressures like poor sleep timing, stress and long sitting act across several body systems at once. That's a reason to cover the network, though it's reasoning, not trial proof.
- So we chose breadth at sensible amounts: every nutrient in 4VIA sits within European safe upper levels, across both formulas combined.
For most of human history, the nutritional problem was simple: not enough. Not enough food, not enough variety, not enough of the right things in winter. Our bodies evolved to make the most of scarcity.
Today, many of us face the opposite problem, at least on the supplement shelf. Vitamin C at ten times the reference amount. B12 at eighty times. The unspoken logic is that if a little is good, a lot must be better.
The evidence doesn't support that logic. And understanding why tells you a lot about how the body actually uses nutrients.
Nutrients don't work alone
Look closely at almost any nutrient and you find it working with others.
Vitamin D helps you absorb calcium. Vitamin K activates proteins, including osteocalcin, that put that calcium to use in bone. Magnesium is needed to process vitamin D itself: in one randomised trial, magnesium changed people's vitamin D levels in different directions depending on where they started.¹ Folate and B12 share one metabolic pathway; B6 runs the next one along.¹¹
Some relationships are rivalries. Take enough zinc for long enough and it blocks copper absorption.¹⁰
This is the basic idea behind systems nutrition: the body runs on networks, not single switches. But it's worth being precise about what it does and doesn't prove. An interaction between two nutrients doesn't mean everyone needs both, or that there's an ideal ratio, or that any particular blend is "synergistic". Trials combining vitamins D and K show some favourable bone markers, but the evidence on fractures is still inconclusive.²˒³
The interactions are real. What they justify is covering the network sensibly, not claiming a blend that beats biology.
When more became worse
The strongest lessons come from trials that went wrong.
In the 1990s, a Finnish trial gave 29,000 male smokers beta-carotene, the orange pigment in carrots, at 20 mg a day. Lung cancer rose by 18%.⁵ A decade later, the SELECT trial gave 35,000 men 400 IU of synthetic vitamin E a day. Prostate cancer rose by 17%.⁶
These results are specific. They don't mean carrots are dangerous, or that every dose of vitamin E is. They concern particular forms, doses and populations. But they show that a nutrient isolated from food, at a dose far beyond a normal diet, can behave very differently.
There are quieter examples too. Too much vitamin B6 over time can damage nerves; Europe's food-safety authority set the adult upper level at 12 mg a day for that reason.⁷ In a three-year trial, older adults given 4,000 or 10,000 IU of vitamin D a day gained no bone strength, and the highest dose was linked with lower bone density at the wrist.⁹
A pattern runs through these findings. Correcting a shortfall can matter a great deal. Piling more on top of enough usually doesn't, and sometimes it costs you.
What the broad trials actually show
If high single doses disappoint, what about broad, modest ones?
The largest trials of everyday multivitamins are reassuring and humbling at the same time. The Physicians' Health Study II followed 14,641 male doctors for over a decade. Total cancer was 8% lower in the multivitamin group, a small effect at the edge of statistical significance, with no difference in heart disease.⁸˒¹² COSMOS, with 21,442 older adults, found no significant difference in cancer, heart events or deaths over about three and a half years.¹³
Its cognitive studies found something more interesting: small advantages in memory and overall test scores in the multivitamin group.¹⁴ You may have seen that described as "two years less cognitive ageing". That's a statistical translation of a small difference in test scores. It's not two extra years of life, and it says nothing yet about dementia.
The honest reading: broad, sensible supplementation has modest, measurable effects. It isn't nothing, and it isn't magic.
Why cover the network, not one pathway
There's a second reason I chose breadth, and it comes from how modern life affects the body.
The everyday pressures most of us live with don't act on one system. A mistimed body clock, as in shift work, affects blood sugar control, the immune system, blood pressure and heart rhythm together.¹⁵ Psychological stress reaches the mitochondria that make energy inside our cells.¹⁶ Long periods of sitting have their own effects on metabolism and blood vessels.¹⁷ The same few hubs keep appearing: inflammation, the body's clock, metabolism, the stress response and the gut.
If the pressures are spread across the network, it makes sense for daily nutrition to be spread across it too, at sensible amounts, rather than concentrated in one heroic dose.
I want to be clear about what kind of argument this is. It's reasoning from the evidence, not proof from a trial. No study has shown that a broad formula offsets modern-life strain. And no supplement replaces the basics that act on all those hubs at once: sleep, movement, a varied diet. What the reasoning does is explain the shape of the formula. (Read: Why ageing is multi-system.)
How this shaped 4VIA
When I formulated 4VIA, I used this evidence as guard rails rather than a sales argument.
- Breadth first. The morning formula covers the full range of vitamins and minerals plus botanicals, cultures and longevity ingredients, because the body's needs are networked.
- Sensible amounts. Most vitamins and trace minerals sit at 100–300% of the label reference (NRV). Calcium and magnesium sit lower, because they're heavy and food supplies most of them.
-
A few higher on purpose, each for a reason.
- Vitamin D3, 50 µg (1,000% NRV): the label NRV is only 5 µg, while NHS advice is 10 µg a day for many adults in autumn and winter. 50 µg is half the European upper level of 100 µg.
- Vitamin B12, 24 µg (960%): the body absorbs only a small fraction of a larger oral dose, and EFSA hasn't set an upper level (the data weren't enough to set one, which isn't the same as proof of safety at any dose). 24 µg is a fraction of the 80-fold doses common on the shelf.
- Biotin, 300 µg (600%), and vitamin C, 450 mg (563%): both water-soluble and without an EFSA upper level. Vitamin C's known side effect, stomach upset, appears at gram doses; biotin at many milligrams can distort some blood tests. Ours are far below both.
- Within safe upper levels, both formulas combined. Zinc across ISN™ and Rest Phase™ totals 17 mg, under the 25 mg upper level. B6 is 2 mg against a 12 mg ceiling. Magnesium is split between morning and night to stay well within the 250 mg limit for supplemental magnesium.
- Partners together. D3 with K2 and magnesium; zinc with copper; folate with B12 and B6.
These are the principles I'd want from any formula: cover the gaps, respect the ceilings, and don't mistake a bigger number for a better one.
What we still don't know
- Which people actually benefit from broad supplementation? It probably depends on diet and on where you start, but trials rarely tell us who.
- Does any combination produce effects beyond its individual ingredients at everyday doses? That would need a factorial trial nobody has run.
- Do small differences in cognitive scores add up to anything you'd notice over decades?
These are the right questions to ask any brand, including us.

References
- Dai Q et al. Am J Clin Nutr. 2018;108:1249–1258. doi:10.1093/ajcn/nqy274
- Kuang X et al. Food Funct. 2020;11:3280–3297. doi:10.1039/C9FO03063H
- Mott A et al. Osteoporos Int. 2019. PMID 31076817
- Martí-Carvajal AJ et al. Cochrane Database Syst Rev. 2017;8:CD006612
- ATBC Study Group. N Engl J Med. 1994;330:1029–1035. doi:10.1056/NEJM199404143301501
- Klein EA et al. JAMA. 2011;306:1549–1556. doi:10.1001/jama.2011.1437
- EFSA NDA Panel. EFSA J. 2023;21:e08006. doi:10.2903/j.efsa.2023.8006
- Gaziano JM et al. JAMA. 2012;308:1871–1880. doi:10.1001/jama.2012.14641
- Burt LA et al. JAMA. 2019;322:736–745. doi:10.1001/jama.2019.11889
- NIH ODS. Copper fact sheet, checked 2026
- NIH ODS. Folate fact sheet, checked 2026
- Sesso HD et al. JAMA. 2012;308:1751–1760. doi:10.1001/jama.2012.14805
- Sesso HD et al. Am J Clin Nutr. 2022. PMID 35294969
- Vyas CM et al. Am J Clin Nutr. 2024. PMID 38244989
- Kervezee L et al. Eur J Neurosci. 2020;51:396–412. doi:10.1111/ejn.14216
- Picard M, McEwen BS. Psychosom Med. 2018;80:141–153. doi:10.1097/PSY.0000000000000545
- Pinto AJ et al. Physiol Rev. 2023;103:2561–2622. doi:10.1152/physrev.00022.2022
Upper levels: EFSA/SCF Overview of Tolerable Upper Intake Levels, v11, Aug 2025. NRVs: Reg. 1169/2011 Annex XIII.



